H Bonig Selected Research

3- (1,3- benzodioxol- 5- yl)- 3- ((((- 1- ((bis(2- thienylmethyl)amino)carbonyl)pentyl)amino)carbonyl)amino)propanoic acid

10/2014

Effects of the small-molecule inhibitor of integrin α4, TBC3486, on pre-B-ALL cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Bonig Research Topics

Disease

1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022
1	Infections 10/2017
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 10/2014
1	Neoplasms (Cancer) 11/2001

Drug/Important Bio-Agent (IBA)

1	Chimeric Antigen ReceptorsIBA 01/2022
1	EpitopesIBA 10/2017
1	Pharmaceutical PreparationsIBA 10/2017
1	3- (1,3- benzodioxol- 5- yl)- 3- ((((- 1- ((bis(2- thienylmethyl)amino)carbonyl)pentyl)amino)carbonyl)amino)propanoic acidIBA 10/2014
1	IntegrinsIBA 10/2014
1	CytokinesIBA 11/2001
1	Interleukin-2 (IL2)IBA 11/2001
1	Interleukin-1 (Interleukin 1)IBA 11/2001

Therapy/Procedure

1	Hematopoietic Stem Cell Transplantation 10/2017
1	Immunotherapy 11/2001